CRISPR: The Complete Guide to Genome Editing and the Future of Genetic Medicine

     Imagine fixing the exact genetic mutation responsible for a lifelong disease, growing crops that can withstand droughts and/or reprogramming the patient's own immune cells to hunt down cancer. It was science fiction a few decades ago. Today, it's just regular lab tasks and the technology that makes it possible is CRISPR, the gene-editing technology reshaping modern medicine.

CRISPR technology allows scientists to make precise, targeted edits to DNA

CRISPR has become the most useful tool in modern genetic engineering and is capable of editing almost any gene in almost any organism in a quick and inexpensive way, which is what no previous method could do. It has revolutionized biomedical research, agriculture, diagnostics, and medicine over the past decade. More recent developments like base editors, prime editors, and RNA-targeting systems can now enable changes that are much more specific, such as replacing a single letter of the DNA without cutting the genome. In fact, artificial intelligence has also been brought into the mix, and it is used to create more effective guide molecules, and to predict the effects of an edit before it's put into the laboratory.

CRISPR is not a finished technology, though. As CRISPR-based treatments move to real patients, questions surrounding the use of these technologies remain to be solved, including questions of safety, unintended edits, ethics, and fair access. This guide provides an overview of what CRISPR is, how it works, areas in which it is currently being applied and future challenges.

1. What Is CRISPR? : The Basics of CRISPR Gene Editing

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and is a natural immune system mechanism that bacteria and archaea use to defend against viruses. Long before scientists recognized its potential as a genome-editing tool, microorganisms relied on CRISPR as an adaptive immune system to defend themselves against invading viruses known as bacteriophages.

Read More: Editing the Future: The CRISPR Revolution in Modern Medicine

When a virus attacks a bacterium, fragments of the viral DNA are captured and placed into specific parts of the bacterial genome known as CRISPR arrays. The DNA fragments stored in the cells are a molecular memory of past infections. if the same virus enters the cell, the bacterium transcribes these stored sequences into short pieces of RNA that direct CRISPR-associated (Cas) proteins to cut up the viral DNA so that it cannot replicate. This incredible defense mechanism allows bacteria to give themselves an inherited immunity to a repeated viral attack.

How CRISPR works as a natural bacterial immune system against viral infection

Researchers soon found out that this natural defense mechanism could be harnessed as a powerful genome-editing tool. By designing a custom guide RNA that matches virtually any DNA sequence of interest, researchers can direct Cas proteins to specific locations within a genome. Once the target DNA is recognized, the Cas enzyme precisely cuts the DNA, allowing cellular repair mechanisms to modify, delete, or replace genetic information.

2. What Is Genome Editing? : Genome Editing vs. Gene Therapy Explained

Genome editing refers to the purposeful modification of an organism's genome by the insertion, deletion, or alteration of specific sequences of genes. Instead of altering the whole genome, genome editing can be used to specifically target genes known to play a specific role in a biological function or disease.

The ability to edit genomes has revolutionized biological research because it enables scientists to directly investigate how individual genes contribute to health and disease. Scientists can turn genes off or turn them on to see what they do, fix faulty genes, add desirable ones, or create new biological traits.

Prior to the advent of CRISPR, genome editing was largely based on engineered nucleases, including zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). While these technologies represented significant scientific advances, designing them for each new DNA target was technically demanding, labor-intensive, and expensive. They were too complex to be used widely, especially for routine laboratory research.

Read More: Remarkable Breakthrough: Man Unexpectedly Cured of HIV After Stem Cell Transplant

CRISPR revolutionized genome editing by replacing the time-consuming and labour intensive process of protein engineering with a simple programmable RNA molecule. Scientists do not need to redesign an entire new protein for each target gene, they simply need to manipulate the guide RNA sequence using the same Cas protein.

 It is important to distinguish two terms which are frequently used interchangeably: 

• Genome editing:  The technical process of altering DNA. 
• Gene therapy:  The more general medical objective to treat or prevent disease by altering the genetic material. CRISPR is simply the best tool currently available for gene therapy, because it can correct the root cause of a disease rather than just adding a replacement gene.

CRISPR is simply the best tool currently available for gene therapy because it can correct the root cause of a disease rather than just adding a replacement gene.

3. History of CRISPR: From Bacterial Immunity to the Nobel Prize

CRISPR's story spans nearly four decades moving from an unexplained biological curiosity to a Nobel Prize winning technology: 

• 1987: Japanese researchers studying Escherichia coli (E. coli) noticed a series of unusual repetitive DNA sequences separated by unique spacer regions. Scientists at the time didn't know what these sequences were, nor did they know what they did. 
• 1990s: Closely related repeats are found in many other bacteria and archaea, indicating their biological significance. 
• In the early 2000s, scientists find that the spacer sequences are similar to pieces of viral DNA. This discovery stimulated the scientists to suggest that bacteria were retaining fragments of viral DNA as molecular memory, so they could detect and resist future attacks by viruses. 
• 2002: The term CRISPR is officially coined, and nearby genes encoding CRISPR-associated (Cas) proteins are identified, laying the foundation for understanding how the CRISPR system functions. 
• 2007: The researchers show experimentally that CRISPR functions as an adaptive immune system in bacteria and that they can become resistant to bacteriophages by adding parts of viral DNA to the CRISPR arrays, giving them sequence-specific immunity to any subsequent attacks. 
• In 2012, it was found that Cas9 could be engineered to use a custom guide RNA (sgRNA) to cut virtually any DNA sequence, making an immune system defense mechanism into a genome editing platform. 
• 2013: Independent labs prove the CRISPR-Cas9 is not limited to bacteria when they successfully edit genes within mammalian cells for the first time. 
• 2016: First human clinical trial of CRISPR-based therapy begins. 
• 2020: Emmanuelle Charpentier and Jennifer Doudna win the Nobel Prize in Chemistry for developing CRISPR-Cas9 as a programmable editing tool. 
• 2023 onward: First CRISPR therapy approved for clinical use (sickle cell disease and beta-thalassemia) and dozens of new therapies reach clinical trials, base editing, prime editing and variants of Cas12/Cas13 make the list of what's being edited longer.

Read More: In-Vivo CAR-T Cell Therapy: A Game-Changing Approach in Cancer Immunotherapy

4. Components of the CRISPR-Cas9 System: Cas9, Guide RNA, and PAM Explained

Several molecular components are required to work together for the remarkable precision that the CRISPR-Cas9 system achieves. Each serves a distinct function in recognition of the target DNA, introducing a specific cut and starting the genome-editing process.

The three core components of the CRISPR-Cas9 system: Cas9 protein, guide RNA, and target DNA

Cas9 Protein

The Cas9 protein is the central enzyme responsible for cutting DNA. Often described as molecular scissors, is an endonuclease enzyme that can induce a double strand break at a precise site in the genome. However, Cas9 cannot locate its target on its own. Instead, it relies on a guide to direct it to the correct DNA sequence. After binding to the target, Cas9 makes a very specific cut, enabling the cell's own DNA repair system to modify the genome.

Guide RNA (gRNA)

The guide RNA (gRNA) determines where Cas9 cuts the DNA. It has a sequence that is complementary to the targeted gene, allowing the CRISPR system to locate the appropriate position in the genome. Researchers can easily retarget Cas9 to any gene by modifying the guide RNA sequence without altering the protein itself. One of the greatest advantages of CRISPR over previous genome-editing technologies is its programmability.

In nature, the bacterial CRISPR system uses two separate RNA molecules:

• CRISPR RNA (crRNA): Provides sequence specificity by matching the target DNA. 
• Trans-activating CRISPR RNA (tracrRNA): Binds to the crRNA and activates Cas9.
• For ease of the lab application, these two RNAs were merged into a single molecule called the single-guide RNA (sgRNA) which carries out both functions and simplifies the system's design and use. 
• Protospacer Adjacent Motif: The PAM is a short DNA sequence located immediately next to the target site. Cas9 must first recognize the PAM before it can bind to the DNA and initiate cleavage. For the commonly used Streptococcus pyogenes Cas9 (SpCas9), the PAM sequence is typically 5′-NGG-3′, where N can represent any nucleotide. Even if the guide RNA is a perfect match to the target sequence, without an appropriate PAM, Cas9 will not be able to bind or cut the DNA. This requirement makes targets more specific and assists the bacteria to know the foreign DNA from their genome.

5. How CRISPR Works: The CRISPR-Cas9 Gene Editing Process Step by Step

While CRISPR might seem very complicated, the CRISPR genome-editing process can essentially be described as a series of coordinated molecular events.

 Step 1: Designing the Guide RNA

The first step involves designing the guide RNA.The first step is to design the guide RNA. To edit a gene, the scientists need to find the gene of interest and create a guide RNA with a sequence that matches the DNA in the region of interest. This guide RNA functions as the "map" which directs Cas9 to the proper address within the genome.

Step 2: Formation of the CRISPR Complex

The guide RNA binds to the Cas9 protein, forming a ribonucleoprotein complex. This complex is responsible for searching the genome for a DNA sequence that matches with the guide RNA and contains a suitable PAM sequence.

Step 3: Target Recognition

Once Cas9 encounters a PAM sequence, it temporarily unwinds the DNA. When the adjacent DNA sequence is completely complementary to the guide RNA, Cas9 conformationally changes and activates its nuclease domains. The verification process helps to minimize unwanted DNA cutting.

Step 4: DNA Cleavage

Activated Cas9 cuts both strands of the DNA, creating a double-strand break (DSB). It is this exact break that is crucial as it activates the natural DNA repair mechanisms of the cell for genome editing.

Step 5: DNA Repair

The cell repairs the break with one of two pathways, and which pathway is taken determines the outcome of the editing. 

• Non-Homologous End Joining (NHEJ): NHEJ is the cell's fast, "just glue it back together" repair option. It is not template-based and therefore prone to errors. It frequently leaves small insertions or deletions (known as indels) at the cut site. Scientists make use of this to intentionally disable genes and observe their functions.  
• Homology-Directed Repair (HDR): HDR is the precise option which leverages a provided DNA template to repair the break in the exact way it was intended, allowing scientists to fix a mutation or introduce new DNA. The problem is that HDR only is efficient in limited stages of cell division, and this is a major challenge in precision editing today. 

Read More: The Google of DNA: A New Search Engine for the Genetic World

Researchers tilt HDR the other way with inhibitors of NHEJ components, molecules that increase the amount of repair protein RAD51, and engineered Cas9 fusions that bring repair machinery to the cut site.

After CRISPR-Cas9 cuts DNA, the cell repairs it via NHEJ (gene knockout) or HDR (precise gene correction)

6. Types of CRISPR Technologies: Cas9, Cas12, Cas13, Base and Prime Editing

Although CRISPR-Cas9 remains the most widely used genome-editing system, ongoing research has led to the development of several advanced CRISPR technologies. These newer systems address some of the shortcomings of the original Cas9 platform, and enhance the precision of editing. They create a multi-purpose toolbox for scientists to modify DNA and RNA in various ways and to suit different purposes.

CRISPR-Cas9

CRISPR-Cas9 is the first and best studied genome editing platform. It relies on a programmable guide RNA (gRNA) to guide the Cas9 protein to a specific DNA sequence where the Cas9 makes a double-stranded break. The cell then repairs this break by two processes: non-homologous end joining (NHEJ) and homology-directed repair (HDR) which may result in disruption, correction or insertion of the gene. Cas9 is the backbone of genome editing and for this reason, it is considered to be simple, efficient and versatile.

 

CRISPR-Cas12

A second type of CRISPR enzyme that is different from Cas9 in structure and function. Unlike Cas9 that leaves blunt-ended breaks in DNA, Cas12 leaves sticky ends. It also needs an alternative PAM sequence for identification. Cas12 is unique in its collateral cleavage activity, where the activated enzyme can randomly cleave single-stranded DNA in its vicinity. Scientists have tapped into this feature to create extremely sensitive diagnostic devices for the detection of viral infections, genetic mutations, and other biomarkers, with remarkable accuracy.

CRISPR-Cas13

Unlike Cas9 and Cas12 which target DNA, Cas13 targets RNA. Cas13 is a reversible method for regulating gene expression, since it works on RNA rather than permanently changing the genome. It is particularly important in research on gene function, antiviral drug development, and the production of quick and easy diagnostic tests for infectious diseases. The COVID-19 pandemic illustrated the use of Cas13-based diagnostic systems to rapidly detect pathogens and with high sensitivity.

Base Editing

The traditional approach to CRISPR editing involves the creation of double stranded DNA breaks that can result in unwanted mutations. Base editing was developed to overcome this limitation by directly converting one DNA base into another without cutting both strands of DNA. For example, a cytosine (C) can be converted into thymine (T), or adenine (A) into guanine (G). Base editing has emerged as a promising approach to correcting the pathogenic variants with greater precision and fewer unwanted genetic changes, because many inherited diseases are caused by single-base mutations.

 Prime Editing

It is one of the most advanced genome editing technologies today. A modified Cas protein is paired with a reverse transcriptase enzyme and a specialized guide RNA to allow precise editing of base substitutions, insertions, and deletions without the formation of double-strand DNA breaks, making prime editing a "search-and-replace" technology for the modification of DNA. The method can greatly decrease the chance of unwanted mutations and greatly increase the number of potential genetic modifications.

High-Fidelity CRISPR Systems

The risk of off-target editing is one of the biggest concerns with CRISPR technology: DNA sequences that are similar to the intended target are accidentally cut. To overcome this challenge, researchers have developed high fidelity versions of Cas9 that are more specific. The modified enzymes preserve high genome editing efficiency, but they significantly decrease non-intended DNA cleavage, making them more applicable for therapeutic applications, where safety is a major concern.

Read More: The Hidden Secret to Strong Teeth: How Oral Probiotics Transform Your Dental Health Naturally

Epigenome Editing

Some diseases do not involve permanent changes to DNA sequences. Epigenome editing involves the use of a modified CRISPR protein that does not cut DNA, but instead guides it to a region of the genome where it changes epigenetic marks to switch the gene on or off. This technology enables scientists to examine how genes are regulated, and could also be used to develop treatments for diseases resulting from the abnormal regulation of genes, without altering the genetic code permanently.

CRISPRa and CRISPRi

Researchers have also created CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) systems. Both use a catalytically inactive Cas9 protein (dCas9) that binds DNA without cutting it. 

• CRISPRa increases gene expression by recruiting transcriptional activators. 
• CRISPRi is a method that prevents the expression of genes by blocking transcription or by bringing in inhibitory proteins.

These strategies are useful for examining the function of genes without any long-term genetic change, and can be effective at screening for potential therapeutic targets.

7. Applications of CRISPR in Different Fields: Medicine, Agriculture, and Biotechnology

CRISPR's versatility has revolutionized many fields of science. From the treatment of inherited diseases to enhancing crop productivity or speeding up drug discovery, CRISPR has emerged as one of the most impactful technologies in contemporary biology.

Medicine and Gene Therapy

A large number of inherited disorders are caused by mutations in a single gene, which are good targets for genome editing. Whereas, rather than managing symptoms CRISPR could potentially be used to fix the underlying defect in the genes. CRISPR therapies are currently under investigation for a wide variety of genetic disorders, such as sickle cell disease, β-thalassemia, cystic fibrosis, Duchenne muscular dystrophy, hemophilia, and inherited retinal diseases. By repairing disease-causing mutations or restoring normal gene function, CRISPR has the potential to provide long-lasting or even curative treatments for conditions that were previously considered incurable.

In addition to inherited disorders, the use of CRISPR is also being investigated for treating autoimmune disorders, cardiovascular disorders, neurological disorders, and metabolic disorders. New delivery methods like viral vectors and lipid nanoparticles further enhance the potential for clinical gene editing therapies.

Cancer Research and Precision Oncology

An exciting potential area where CRISPR can be applied is cancer research. CRISPR is not a cure for all cancers but it can be used to gain a better understanding of tumor biology, identify novel targets for intervention, and to create individualized immunotherapies.    

 The most promising application is the use of CRISPR modified CAR-T cells. The idea behind this is to modify the immune system cells of a patient so that they are better able to recognize and destroy cancerous cells. CRISPR can also remove genes that suppress immune responses, thereby enhancing the ability of T cells to attack tumors.

CRISPR is also used by researchers to generate precise models of cancer by adding the correct mutations to laboratory cells and animals. The models can be used to examine the development of cancers, to understand the mechanisms of drug resistance, and to test new therapies before they are tested on people. In addition, genome-wide CRISPR screening allows researchers to discover genes that promote cancer progression or affect how the disease responds to treatment, speeding up the identification of novel targets for drug discovery.

Read More: Why Your Mom Might Influence Your Intelligence More Than Your Dad

Agriculture

CRISPR has revolutionized agricultural biotechnology by making it easy to produce improved crop varieties in a short period without the addition of foreign DNA. By making specific changes to genes with desirable traits, scientists can precisely modify the genes and design crops more efficiently than they can do using traditional breeding methods.

Current applications include:

• Disease-resistant crop varieties
• Improved drought and heat tolerance
• Higher yields
• Improved nutritional content
• Longer shelf life
• Reduced dependence on pesticides and chemical fertilizers

Livestock Improvement

CRISPR is also being used to improve animal health and productivity. Researchers are developing livestock with increased resistance to infectious diseases, improved growth characteristics, and enhanced reproductive performance. Gene editing may also reduce the need for antibiotics in animal farming, contributing to healthier livestock production systems while improving food security.

Drug Discovery and Functional Genomics

Identification of a viable drug target typically takes years and vast expenditures. CRISPR screening accelerates this process by editing thousands of genes in a single cell at a time and determining which ones impact the disease's progression or drug sensitivity. It has led to the identification of potential drug targets in liver cancer, pancreatic cancer, and brain tumor, and is being used more and more alongside cells taken from patients to determine what drugs will be beneficial for each person's individual treatment.

CRISPR in Diagnostics

Although CRISPR is best known for genome editing, it is also transforming disease diagnosis. CRISPR proteins including Cas12 and Cas13 are able to precisely target the specific DNA or RNA sequence, making the development of rapid and sensitive diagnostic platforms like SHERLOCK and DETECTR possible. The tests are fast, inexpensive and do not require a lot of laboratory material, and have a great value in detecting infectious diseases, mutations associated with cancer, inherited disorders, and other biomarkers employed in precision medicine.

Biotechnology and Synthetic Biology

Besides human healthcare applications, the technology of CRISPR is also necessary to produce custom-made microorganisms for the industrial synthesis of pharmaceuticals, biofuels and enzymes, or to build synthetic genetic circuits and organisms for particular purposes, including waste degrading and environmental monitoring.

8. Benefits of CRISPR: Why CRISPR Outperforms Older Gene-Editing Tools

There are many reasons for this, including the fact that CRISPR is much easier to use than previous genome editing methods and is far more efficient. It is simple, efficient and versatile and has revolutionized biological research and new possibilities in several fields.

• Precision: The guide RNA can be used to edit a particular piece of DNA very accurately.
• Simplicity: A major advantage of retargeting CRISPR to a new gene is that instead of redesigning a protein, only the guide RNA needs to be changed.
• Cost-Effectiveness: Much more cost-effective than previous technologies such as ZFNs and TALENs.
• Versatility: The same core system can disrupt genes, correct mutations, control gene activity, edit RNA or modify epigenetic marks.
• Multiplexing: Several genes can be edited simultaneously, useful for studying complex diseases involving many genes at once.

Read More: A Sinister Brain Protein and the Deep Mystery of Life’s Origins

9. Risks and Limitations: Off-Target Effects and Delivery Challenges

Although there are significant advantages to the use of CRISPR, there are still several scientific and technical hurdles that need to be overcome before it can be used in the clinic broadly. 

• Off-target effects: Cas enzymes sometimes cleave DNA sequences that are only partially complementary with the target sequence, which can have off-target effects and affect important genes. This risk can be mitigated by using high fidelity variant Cas9s and computational prediction tools. 
• Delivery: Getting the editing machinery safely into the right cells and tissues remains one of the toughest unsolved problems, especially for organs beyond the liver and blood. 
• Low efficiency of HDR: Only a small number of edits are corrected precisely, and the majority are made by the less precise NHEJ pathway. 
• Immune reactions: Cas9 is a bacterial protein, so the human immune system can identify it as a foreign invader. The effectiveness of therapy is hindered in some individuals by pre-existing antibodies and reactive cells of the immune system. Engineering less-recognizable Cas variants and using short-lived delivery methods are current solutions. 
• Unintended genomic changes: Large deletions or chromosomal rearrangements have been observed as rare side effects of DNA cutting. 
• PAM restrictions: Only regions adjacent to PAM sequences are directly accessible for editing by Cas9, but engineered variants with relaxed PAM requirements are filling this gap.

10. Ethical Considerations: Germline Editing and the Designer Babies Debate

The new developments in CRISPR have raised pertinent ethical issues. It has the potential to be used as a treatment for genetic diseases, but there are also concerns about using it for this purpose. 

The chief issue is with germline genome editing, where changes to the genome of an embryo, sperm or egg might also be passed down to future generations.

 One of these is the possibility of designer babies -- genes could be manipulated to enhance the traits, and not just to cure the disease. Furthermore, there could be significant healthcare disparities since CRISPR therapies are expensive. To overcome these problems, scientists and policy makers are developing guidelines and protocols to ensure that CRISPR is used safely, ethically, and responsibly – most of whom favor somatic gene editing for medical applications and recommend prudence in germline editing.

11. Future of Genetic Medicine: AI, Precision Medicine, and Next-Gen CRISPR Tools

CRISPR has already transformed biological research, and likely more will be available in the future. The continued development of genome-editing technologies will bring more safety, precision and accessibility to future therapies.

AI and advanced lab technology are shaping the next generation of CRISPR-based genetic medicine 

• Safer and more precise therapies: CRISPR advances are bringing genome editing to a more precise and safer level. 
• Next-generation editing tools: Advances such as base editing and prime editing have the potential to fix disease-causing mutations with increased accuracy.  
• AI-powered genome editing: AI technologies are being used to optimize guide RNAs and to predict off-target effects and enhance genome editing efficiency. 
• Personalized medicine: CRISPR will be vital for the advancement of personalized treatments based on a person's genetic code. 
• Expanded medical applications: Future advances may improve treatments for genetic disorders, cancer, infectious diseases, and support regenerative medicine. 
• A promising future: Despite the challenges of technical and ethical issues, CRISPR is poised to play a significant role in the future of healthcare and precision medicine.

Read More: Predicting Human Genetic Variants in Mice: A Game Changer for Genomic Research

12. Conclusion

The CRISPR system has been transformed modern biology from a bacterial defense system to an innovative genome editing technology. It is extremely precise and so versatile that it has provided other possibilities in medicine, agriculture, biotechnology, diagnostics and drug research. Despite the risks, technical hurdles, and ethical considerations, the future of genome editing is promising, and continued innovation in this field will enhance its applications. In the hands of responsible development and regulation, CRISPR is likely to become a key component of precision medicine, and influence the future of genetic health care.

Frequently Asked Questions

What is CRISPR and how does it work?

CRISPR is a gene-editing technology adapted from a natural bacterial immune system. A guide RNA directs the Cas9 protein to a specific DNA sequence, where Cas9 cuts both strands. The cell's own repair machinery then fixes the break, allowing scientists to disrupt, correct, or insert genetic material.

What is CRISPR-Cas9 used for?

CRISPR-Cas9 is used to edit genes in research, medicine, agriculture, and biotechnology. Applications include correcting disease-causing mutations, engineering CAR-T cells for cancer therapy, developing disease-resistant crops, and creating rapid diagnostic tests for infectious diseases.

Is CRISPR gene editing safe?

CRISPR is generally considered safe for research and approved clinical uses, but risks remain, including off-target effects, immune reactions to the Cas9 protein, and unintended genomic changes. Ongoing improvements like high-fidelity Cas variants aim to reduce these risks.

What diseases can CRISPR treat?

CRISPR-based therapies are approved or under investigation for sickle cell disease, beta-thalassemia, cystic fibrosis, Duchenne muscular dystrophy, hemophilia, inherited retinal diseases, and certain cancers, among other genetic conditions.

What is the difference between genome editing and gene therapy?

Genome editing is the technical process of altering DNA sequences, while gene therapy is the broader medical goal of treating or preventing disease by changing a patient's genetic material. CRISPR is currently the most precise tool available for achieving gene therapy.

What is the difference between base editing and prime editing?

Base editing changes a single DNA letter without cutting both strands of the double helix, while prime editing uses a modified Cas protein and reverse transcriptase to write new genetic sequences directly, enabling a wider range of precise edits without double-strand breaks.

What are the main risks and limitations of CRISPR?

Key limitations include off-target effects, low efficiency of homology-directed repair, delivery challenges in getting editing components into the right cells, immune reactions to Cas9, and restrictions based on PAM sequence availability near the target site.